iEdison Invention, 

Patent, and Utilization 

(IPU)

Bulk Upload v2.0 Specifications and Examples

September 13, 2023

NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY (NIST) 

 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

2

Contents 

1 Scope ..............................................................................................................................................................................4

2 File and Data Format ......................................................................................................................................................4

3 Upload and Process........................................................................................................................................................4

4 Data Elements and Details..............................................................................................................................................5

4.1 Invention Data Element and Details ...................................................................................................................6

4.2 Patent Data Element and Details........................................................................................................................7

4.3 Utilization Data Element and Details..................................................................................................................8

5 Examples.......................................................................................................................................................................24

5.1 Create Invention Example.................................................................................................................................24

5.2 Create Invention, Patent, and Utilization Example...........................................................................................24

5.3 Create Invention and Multiple Patent Reports Example ..................................................................................25

5.4 Create Invention and Utilization Reports Example...........................................................................................26

5.5 Create a Utilization Report with Development Stage (Not Licensed or Commercialized) with NIH Funding 

Example ........................................................................................................................................................................27

5.6 Create a Utilization Version 2 with Development Stage as “Licensed” Example .............................................27

5.7 Create a Utilization Report with Development Stage (Commercialized) with NIH Funding Example..............28

5.8 Create a Utilization Report for 2023 and after (Commercialized with DOE and NIH Questions).....................29

5.9 Create a Utilization Report for 2023 and after (Commercialized and has both NIH and DOE funding)...........30

5.10 Update Invention Report Examples..................................................................................................................31

5.11 Update Patent Report Examples.......................................................................................................................32

5.12 Update Utilization Examples.............................................................................................................................32

6 Lookups.........................................................................................................................................................................33

6.1 Agency List and Abbreviation ...........................................................................................................................33

6.2 Award Type .......................................................................................................................................................34

6.3 Agreement Type................................................................................................................................................34

6.4 Title Election Status...........................................................................................................................................34

6.5 State List............................................................................................................................................................35

6.6 Country List.......................................................................................................................................................37

6.7 Patent Status.....................................................................................................................................................43

6.8 Patent Type .......................................................................................................................................................43

6.9 Foreign Filing Status..........................................................................................................................................43

6.10 Reporting Year ..................................................................................................................................................43
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

3

6.11 Latest Development Stage ................................................................................................................................44

6.12 First Commercial Sale........................................................................................................................................44

6.13 Type of date of manufacturer...........................................................................................................................45

6.14 Government review status................................................................................................................................45

6.15 FDA Approval Type............................................................................................................................................45

6.16 Commercialization Plans...................................................................................................................................45
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

4

1 Scope 

This document depicts the prerequisites, data elements, and file formats for the invention, patent, and 

utilization (IPU) bulk upload process version 2. It should be noted that these requirements are solely 

applicable to utilization submissions made after 2023.

2 File and Data Format 

Any organization may take advantage of this bulk upload service. However, organizations who want to 

utilize the bulk upload service first need to make sure that they have “Enable Bulk Upload” checked in 

their iEdison organization profile. Once an organization has bulk upload enabled, the system only 

requires that the information be transferred to the iEdison format in plain (ASCII) text.

Note: Max. upload file size is 4 MB 

The bulk upload file content is generally constructed as a sequence of data element name-value 

pairs as presented below. 

data element name 1=^^data element value^^ data 

element name 2=^^data element value^^ data 

element name 3=^^data element value^^ data 

element name 4=^^data element value^^ 

 . . . . 

 . . . . 

 . . . . 

data element name n=^^data element value^^ 

Note: The data elements must be provided in a specific format and same sequence. 

The first line of the bulk file content must contain one of the following predefined value PRODUCTION. See 

examples in Examples Section 5

3 Upload and Process 

Once the data to be transmitted is in the proper format within a file on your local computer, you can 

upload your file to the iEdison system. 

Method: 

• Login to the iEdison System 

• Navigate to the main menu and under "Bulk Upload," click on “Bulk Upload.” 

• The Bulk Upload page will load. 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

5

• Click on the “New Upload” button in the top right corner.

• Using the “Open” dialog box, select a file you want to upload and click the “Open” button to 

upload the document. 

• Your file has been uploaded and will be processed shortly. The results of the upload will be 

shown when you click on the “View Summary” link and will be emailed to you/your 

organization administrator when complete. 

4 Data Elements and Details 

This section documents the invention, patent, and utilization data element name, data type/size, required, 

and description and explanation in the following sections. Each of the tables contains the data elements 

for the invention, patent, or utilization report. The table header contains the name of the data element, 

the data format and size, the data element status, groups, value selection lookups, and repeats. The 

definitions of the matrix header column titles are listed below. 

• Data Element Name – this column contains the name of the data element to 

be used in the bulk upload file format. 

• Type/Size – this column contains the data element accepted content type and 

size. The element data types are defined below. 

▪ Text – this accepts a string with a character and/or numeric values, 

with a length up to specified maximum size. 

▪ Numeric – this accepts only numeric values.

▪ Date – this accepts a date with the format MM/DD/YYYY (ex: 

01/20/2023).

▪ Lookup – this accepts a predefined value from a given list.

• Required on New – this column contains the flag of Yes or No value to indicate 

if the data element value is required when creating a new record with the Bulk 

Upload feature.

▪ Yes – the data element must have a value in the file content when 

creating a record.

▪ Yes (Conditionally) – the data element must have a value in the file 

content when certain other data element values are provided while 

creating a record. 

▪ No – the data element is optional when creating a record.

• Required on Update – this column contains the flag of Yes or No value to 

indicate if the data element value is required when updating a new record 

with the Bulk Upload feature.

▪ Yes – the data element must have a value in the file content when 

updating a record.

▪ Yes – the data element must have a value in the file content when 

updating a record.
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

6

▪ No – the data element is optional when updating the record. (Noted: 

provide the data element name and value that need update)

• Description/Explanation – this column contains the description, conditionally 

required field rules, and data reference.

4.1 Invention Data Element and Details

This section contains the data element and details for the Invention record. Please refer to the Examples 

section for creating and updating invention record examples.

Data Element Name Type/Size Required 

on New

Required 

on Update

Description/Explanation

EIR.DocketNum Text/30 Yes Yes The institute's internal tracking number for 

the EIR. This Docket number is unique per 

invention for the grantee/award organization.

EIR.PrimaryAgency Lookup Yes No The government agency which receives 

administrative reports and acts as "the 

government" in responding to and inputting 

dates of receipt of documents. This is a lookup 

field; refer to section 6.1 for a list of available 

abbreviation values to use.

EIR.Title Text/100 Yes No Title of the invention as it appears on the 

Invention Report.

EIR.DisclosurDate Date The date the invention was disclosed.

EIR.ParentDocketNum Text/30 No No The institute's internal tracking number for 

the EIR’s parent.

EIR_Grants.Agency Lookup Yes No Name of the agency that has contributed 

funds to the invention. This is a lookup field; 

refer to section 6.1 for a list of available 

abbreviation values to use.

EIR_Grants.GrantNum Text Yes No Number used to identify a specific grant that 

was awarded to an organization.

EIR_Inventor.FirstName Text/80 Yes No Last name of inventor of invention.

EIR_Inventor.LastName Text/80 Yes No First name of inventor of invention.

EIR_Inventor.MI Text/30 No No Middle initial of inventor of invention.

EIR.EIRStatus Lookup No No The status of the Title Election. This is a 

lookup field; refer to section 6.4 for a list of 

available values to use.

EIR.Notes Text/500 No No Note added to the Invention Report to explain 

any discrepancies.

EIR_Keyword.Keyword Text/80 No No One or more keywords to enable an 

organization to designate key terms for 

searching and categorizing Invention 

Reports.
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

7

Table 4-1

4.2 Patent Data Element and Details

This section contains the data element and details for a Patent Report. However, to create or update a 

Patent Report, the Bulk Upload file content must contain the EIR.DocketNum to indicate the Invention 

Report above the patent data element fields. Without EIR.DocketNum, the system will not be able to 

associate the Patent Reports to the correct invention and will return an error message to indicate the 

missing invention data element EIR.DocketNum. Refer to the example sections for examples on creating 

and updating a Patent Report

Data Element Name Type/Size Required 

on Create

Required 

on 

Update

Description/Explanation

Patent.PatDocketNum Text/30 No Yes iEdison unique number used to identify a 

Patent Report.

Patent. PatentTitle Text/255 Yes No The title of the patent as it appears on the 

Patent Report.

Pat_Keyword.Keyword Text/100 No No Keyword of the patent. (No longer used)

Patent.NonProvAppNum Numeric No No Non-Provisional Patent Application Number.

Patent.NonProvAppDate Date No No Non-Provisional Patent Application Date.

Patent.ProvAppNum Numeric No No Provisional Patent Application Number for the 

Patent Report

Patent.ProvAppDate Date No No Provisional Patent Application Date for the 

Patent Report

Patent.PCTNum Numeric No No PCT Application Number for the Patent Report

Patent.PCTFileDate Date No No PCT Application Date for the Patent Report

Patent.PatentNum Numeric No No The patent number assigned by the Patent 

and Trademark Office.

Patent.PatentDate Date No No The date that the patent number was given.

Patent.ExpireDate Date No No Expiration Date for the Patent Report

Patent.TypeOfApplic Lookup No No The type of patent as it appears on the Patent 

Report

Pat_Inventor.FirstName Text/80 Yes No First name of an inventor of a parent Patent 

Report.

Pat_Inventor.LastName Text/80 Yes No Last name of an inventor of a parent Patent 

Report.

Data Element Name Type/Size Required 

on Create

Required 

on 

Update

Description/Explanation

Pat_Inventor.MI Text/30 No No Middle initial of an inventor of a parent Patent

Report.
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

8

Pat_ForeignFiling.Country Lookup No No Country of foreign filing

Pat_ForeignFiling.Status Lookup No No Status of foreign filing

Pat_ForeignFiling.Date Date No No Filing date of foreign filing

Patent.Notes Text/500 No No Note added to the Patent Report to explain 

any discrepancies.

Patent.DispRightsReq Text/80 No No The request by the user, of the disposition of 

the invention if they don't want to prosecute 

it until it expires. * This field had been retired 

and will be ignored by the bulk upload. 

Institutions are required to use the UI to 

submit a request of Void, Assignment, 

Transfer.

Table 4-2

4.3 Utilization Data Element and Details

This section contains the data element and details for the Utilization Reports with reporting year of 2023 

and after. However, to create or update a Utilization Report, the Bulk Upload file content must contain 

the EIR.DocketNum to indicate the Invention Report above the utilization data element fields. Without 

EIR.DocketNum, the system will not be able to associate the utilization to the correct invention and will 

return an error message to indicate the missing data element. Refer to the Examples section for 

examples on creating or updating a utilization. 

Data Element Name Type/Size Required 

on 

Create

Required 

on 

Update

Description/Explanation

Utilize_New.FiscalYear Numeric Yes Yes Fiscal Reporting Year (YYYY) for a 

utilization record. This is a 4 digits year 

value of 2023 and after. Each invention 

record can only have one utilization report 

per fiscal reporting year.

Utilize_New.LatestStageDev Lookup Yes No The Development Stage of development 

of any products related to this Invention 

(EIR) for the current year. Refer to section 

6.11 Latest Development Stage for a list of 

current accepted values.

Utilize_New.ExclusiveLicensesOptions Numeric Yes

(Conditio

nally)

No This is the value for the question “In the 

designated reporting period, how many 

exclusive licenses and/or options are or 

were active?” This is required only when 

LatestStageDev has a value of

“Commercialized” or “Licensed.”

** When this value is 1 or more, the

upload file content can contain the 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

9

Utilize_New.ExclusiveLicenseeName data 

element name and value. For example, if 

this data element value is 3, three 

ExclusiveLicenseeName rows must be 

included in the file to provide the name of 

the exclusive licensees.

Utilize_New.ExclusiveLicenseeName Text/255 Yes 

(Conditio

nally)

No The name of exclusive licensee. This is 

required when 

Utilize_New.ExclusiveLicensesOptions

value is > 0. This can be multiple rows 

based on the value provided in 

ExclusiveLicensesOptions. For example, if 

ExclusiveLicensesOptions = 2, 2 rows of 

Utilize_New.ExclusiveLicenseeName must 

be provided immediately under the 

Utilize_New.ExclusiveLicensesOptions line.

Utilize_New.NonExclusiveLicensesOptions Numeric Yes 

(Conditio

nally)

No This is the value for the question “In the 

designated reporting period, how many 

non-exclusive licenses and/or options are 

or were active?” This is required only 

when LatestStageDev has a value of 

“Commercialized” or “Licensed.”

** When this value is 1 or more, the 

upload file content must contain the 

Utilize_New.NonExclusiveLicenseeName

data element name and value. For 

example, if this data element value is 3, 

three NonExclusiveLicenseeName rows 

must be included to provide the name of 

the non-exclusive licensees.

Utilize_New.NonExclusiveLicenseeName Text/255 Yes

(Conditio

nally)

No Name of non-exclusive license. This is 

required when Utilize_New.

NonExclusiveLicensesOptions value is > 0.

This can be multiple rows based on the 

value provided in 

NonExclusiveLicensesOptions. For 

example, if NonExclusiveLicensesOptions = 

2, 2 rows of Utilize_New. 

NonExclusiveLicenseeName must be 

provided immediately under the 

Utilize_New.NonExclusiveLicensesOptions

line.

Utilize_New.FirstCommSaleYear Numeric Yes

(Conditio

nally)

No This is the digit year (YYYY) value for the 

question “What was the calendar year of 

the first commercial sale?” This is required 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

10

when LatestStageDev has a value of 

“Commercialized” or “Licensed.”

Utilize_New.SmallBusLicensesOptions Numeric Yes 

(Conditio

nally)

No This is the value for the question “In the 

designated reporting period, how many 

licenses and/or options of any type to 

small businesses (as defined by relevant 

SBA regulations) are or were active?” This 

is required when LatestStageDev has a 

value of “Commercialized” or “Licensed”. 

The value can be >= 0.

Utilize_New.TotalIncome Numeric Yes 

(Conditio

nally)

No This is the value for the question “In the 

designated reporting period, what was the 

total gross income received as a result of

license or option agreements? Do not 

include specific patent cost 

reimbursements.”. This is required when 

LatestStageDev has a value of 

“Commercialized” or “Licensed”. The 

value can be >= 0.

Utilize_New.CommercializationPlanId Lookup Yes

(Conditio

nally)

No This is the value for the question “What 

are your current commercialization plans 

for this invention?” This data element is 

required when LatestStageDev has a value 

of “Not Licensed or Commercialized” only. 

Refer to section 6.16 for a list of accepted 

commercialization plans in the Value 

column.

Utilize_New.Notes Text/1000 Yes

(Conditio

nally)

No Utilization general notes. This is required 

only when CommercializationPlanId has a 

value of 5 or 6.

Utilize_New.IsUSManufacturingRequired1 Text/1

(Y or N)

Yes

(Conditio

nally)

No This is the value for the question “Other 

than U.S. Preference (35 U.S.C. 204), is the 

invention subject to any U.S. 

manufacturing requirements (e.g., U.S. 

Competitiveness provision, a U.S. 

Manufacturing DEC, etc.)?” This data 

element is required only when 

LatestStageDev has a value of 

“Commercialized” or “Licensed.”

This is data element accepts value of Y or 

N.

Utilize_New.IsUSManufacturingRequired2 Text/3

(Y, N, or 

N/A)

Yes

(Conditio

nally)

No This is the value for the conditional 

question based on the 

IsUSManufacturingRequired1 element 

value:
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

11

1. If IsUSManufacturingRequired1 element 

has value of N, this data element is for the 

question “In the designated reporting 

period, do all grants to any person having

the exclusive right to use or sell the 

subject invention in the United States 

require that any products embodying the 

subject invention or produced through the 

use of the subject invention will be 

manufactured substantially in the United 

States as required by 35 U.S.C. 204?” This 

data element accepts Y, N, or N/A value.

2. If IsUSManufacturingRequired1 element 

has value of Y, this data element is for the 

question “In the designated reporting 

period, do all licenses include a 

requirement that any products embodying 

the subject invention or produced through 

the use of the subject invention will be 

manufactured substantially in the United 

States (including manufacturing 

requirements other than 35 U.S.C. 204)?” 

This data element accepts Y, N, or N/A 

value.

Utilize_New.IsUSManufacturingRequired3 Text/3

(Y, N, or 

N/A)

Yes

(Conditio

nally)

No This is the value for the conditional 

question based on the LatestStageDev and 

the IsUSManufacturingRequired1 value:

1. If LatestStageDev has value of

“Commercialized” and 

IsUSManufacturingRequired1 element has 

value of N, this element is for the question 

“In the designated reporting period are all 

products embodying the subject invention 

or produced through the use of the 

subject invention manufactured 

substantially in the United States for all 

grants to any person having the exclusive 

right to use or sell the subject invention in 

the United States as required by 35 U.S.C. 

204?” This data element accepts Y, N, or 

N/A value.

2. If LatestStageDev has value of

“Commercialized” and 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

12

IsUSManufacturingRequired1 element has 

value of Y, this element is for the question 

“In the designated reporting period, are all 

products embodying the subject invention 

or produced through the use of the 

subject invention manufactured 

substantially in the United States

(including manufacturing requirements 

other than 35 U.S.C. 204)?” This data 

element accepts Y, N, or N/A value.

Utilize_New.NewUsJobs Numeric Yes

(Conditio

nally)

No This is the value for the DOE specific 

question “Approximate number of new 

US-based jobs created because of 

commercialization efforts during the 

reporting period.” This is required if the 

invention report has DOE as one of the 

funding agencies. The value can be >= 0.

Utilize_New.NewUsCompanies Numeric Yes

(Conditio

nally)

No This is the value for the DOE specific 

question “Number of new US-based 

companies created from the 

commercialization efforts during the 

reporting period.” This is required if the 

invention report has DOE as one of the 

funding agencies. The value can be >= 0.

Utilize_New.ProductName Text/100 Yes

(Conditio

nally)

Yes 

(Condition

ally)

This is the value for the commercial 

product name when the LatestStageDev = 

‘Commercialized” only. The product name 

must be unique in the Utilization Report. 

The same product name cannot be used 

more than one time in a Utilization

Report.

Utilize_New.NaicsCode Text/6 No No This is the value of the North American 

Industry Classification System (NAICS)

code for the commercial product. This 

data element is optional when DOE is one 

of the funding agencies for the invention 

report.

Utilize_New.LicenseeName Text/255 Yes

(Conditio

nally)

No This is the value for the licensee name for 

the commercial product. Each commercial 

product must have one or more licensee 

name. Multiple rows can be added below 

the Utilize_New.ProductName data 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

13

element to add multiple licensees. This is 

required if a product name is provided in 

the Utilization Report.

Utilize_New.ManufacturerName Text/255 Yes 

(Conditio

nally)

Yes 

(Condition

ally)

This is the value for the manufacturer 

name. Each product-licensee association 

can have multiple manufacturers. This is 

required when LicenseeName is provided 

in the commercial product.

Utilize_New.ManufacturerLocationCountry Lookup Yes

(Conditio

nally)

No This is the value for the country where the 

product was manufactured. Each 

manufacturer can have one or more 

countries. Refer to section 6.6 for the 

country name list. The value ‘none’ can be 

used if the country name is not in the list.

This is required when ManufacturerName 

is provided.

Utilize_New.ManufacturerLocationState Lookup Yes 

(Conditio

nally)?

No This is the value for the United States

state name or United States territory 

name where the product was 

manufactured. Each manufacturer can 

have one or more states/territories. Refer 

to section 6.5 for a state/territory value 

list. This is required if Country is UNITED 

STATES.

Utilize_New.ProductQuantity Numeric Yes

(Conditio

nally)

No This is the value for the total number of 

products manufactured at a location. This 

data element is required when DOE is one 

of the funding agencies for the invention 

report this utilization is associated with.

Utilize_New.FirstDate Date Yes

(Conditio

nally)

No This is for the first date of manufacturing 

for the product. This data element is 

required when DOE is one of the funding 

agencies for the Invention Report this 

utilization is associated with.

Utilize_New.FirstDateType Lookup Yes

(Conditio

nally)

No This is the value to indicate if the first date 

of manufacturing is the actual or expected 

date.

Utilize_New.CommercialName Text/80 Yes

(Conditio

nally)

No This is the product name for the FDA

approved commercial product utilizing this 

invention. There can be zero to many FDA 

approved commercial productions for 

each utilization. This data element is 

required when adding a new commercial 

product and NIH is one of the funding 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

14

agencies for the Invention Report this 

utilization is associated with.

Utilize_New.FdaApprovalNumber Text/20 No No This is the FDA approve number for the 

FDA approved commercial product. This is 

an optional data element. If this is used, it 

must be below the 

Utilize_New.CommercialName data 

element.

Utilize_New.FdaApprovalType Lookup No No This is the FDA approve type for the FDA 

approved commercial product. This is an 

optional data element. If this is used, it 

must be below the 

Utilize_New.CommercialName data 

element. Refer to section 6.15 for a list of 

accepted values.

Utilize_New.GovtReviewStatus Lookup No No This is the government review status to 

indicate if the commercial name is FDA 

approved, rejected, or pending. This is an 

optional data element. If this is used, it 

must be below the 

Utilize_New.CommercialName data 

element. Refer to 6.14 for a list of 

accepted values.

Utilize_New.PublicInd Text/1

(Yes or 

No)

No No Indicates if FDA approval for public use or 

not. Notes: Use value of “No” for any FDAapproved product you do not want to 

appear on a publicly available list of 

products arising from your funding 

agreement.

Table 4-3

The utilization report has conditional data element fields that are required based on the provided development stage 

(Utilize_New.LatestStageDev) and the funding agencies for the invention which the utilization is associated with. The 

following sections document the conditional data elements that are required/optional. 

4.3.1 Development Stage as “Not Licensed or Commercialized”

When creating a Utilization with Development Stage as “Not Licensed or Commercial,” the data element fields are 

the same for all different funding agencies except NIH and DOE. Below is a list of the data element names that are 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

15

supported for the bulk upload. If the bulk file content provided any data element fields not listed below, the values 

for the extra data elements will not be imported to the system. Refer to Table 4.3-1 for additional details for the 

data element fields.

• Utilize_New.FiscalYear

• Utilize_New.LatestStageDev

• Utilize_New.CommercializationPlanId

• Utilize_New.Notes 

4.3.2 Development Stage as “Not Licensed or Commercialized” and with Funding from NIH

When creating a Utilization Report with Development Stage as “Not Licensed or Commercial” and the invention has 

funding from NIH, the data element fields have additional FDA approved commercial product fields. Below is a list of 

the data element names that are supported for the bulk upload. If the bulk file content provided any data element 

fields not listed below, the values for the extra data elements will not be imported to the system. Refer to Table 4.3-

1 for additional details for the data element fields.

• Utilize_New.FiscalYear

• Utilize_New.LatestStageDev

• Utilize_New.CommercializationPlanId

• Utilize_New.Notes

• Utilize_New.CommercialName

• Utilize_New.FdaApprovalNumber

• Utilize_New.FdaApprovalType

• Utilize_New.GovtReviewStatus

• Utilize_New.PublicInd

4.3.3 Development Stage as “Not Licensed or Commercialized” and with Funding from DOE

When creating a Utilization Report with Development Stage as “Not Licensed or Commercial” and the invention has 

funding from DOE, the data element fields have additional DOE supplemental question fields. Below is a list of the 

data element names that are supported for the bulk upload. If the bulk file content provided any data element fields 

not listed below, the values for the extra data elements will not be imported to the system. Refer to Table 4.3-1 for 

additional details for the data element fields.

• Utilize_New.FiscalYear

• Utilize_New.LatestStageDev

• Utilize_New.CommercializationPlanId

• Utilize_New.Notes

• Utilize_New.NewUsJobs

• Utilize_New.NewUsCompanies

4.3.4 Development Stage as “Not Licensed or Commercialized” and with Funding from NIH and DOE

When creating a Utilization Report with Development Stage as “Not Licensed or Commercial” and the invention has 

funding from NIH and DOE, the data element fields have additional FDA approved commercial product fields and the 

DOE supplemental question fields. Below is a list of the data element names that are supported for the bulk upload. 

If the bulk file content provided any data element fields not listed below, the values for the extra data elements will 

not be imported to the system. Refer to Table 4.3-1 for additional details for the data element fields.
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

16

• Utilize_New.FiscalYear

• Utilize_New.LatestStageDev

• Utilize_New.CommercializationPlanId

• Utilize_New.Notes

• Utilize_New.CommercialName

• Utilize_New.FdaApprovalNumber

• Utilize_New.FdaApprovalType

• Utilize_New.GovtReviewStatus

• Utilize_New.PublicInd

• Utilize_New.NewUsJobs

• Utilize_New.NewUsCompanies

4.3.5 Development Stage as “Licensed” 

When creating a Utilization Report with Development Stage as “Licensed,” the data element fields are common for 

all funding agencies except for NIH and DOE. If the bulk file content provided any data element fields not listed 

below, the values for the extra data elements will not be imported to the system. Refer to Table 4.3-1 for additional 

details for the data element fields. Specific examples for your reference can be found in section 5 of this document.

• Utilize_New.FiscalYear

• Utilize_New.LatestStageDev

• Utilize_New.ExclusiveLicensesOptions

• Utilize_New.ExclusiveLicenseeName

• Utilize_New.NonExclusiveLicensesOptions

• Utilize_New.NonExclusiveLicenseeName

• Utilize_New.SmallBusLicensesOptions

• Utilize_New.TotalIncome

• Utilize_New.IsUSManufacturingRequired1

o Value for “Other than U.S. Preference (35 U.S.C. 204), is the invention subject to any U.S. manufacturing 

requirements (e.g., U.S. Competitiveness provision, a U.S. Manufacturing DEC, etc.)?

• Utilize_New.IsUSManufacturingRequired2

o If Utilize_New.IsUSManufacturingRequired1 = ‘Y’, this data element value is for “In the designated 

reporting period, do all licenses include a requirement that any products embodying the subject 

invention or produced through the use of the subject invention will be manufactured substantially in the 

United States (including manufacturing requirements other than 35 U.S.C. 204)?”

o If Utilize_New.IsUSManufacturingRequired1 = ‘N’, this data element value is for “In the designated 

reporting period do all grants to any person of the exclusive right to use or sell the subject invention in 

the United States require that any products embodying the subject invention or produced through the 

use of the subject invention will be manufactured substantially in the United States as required by 35 

U.S.C. 204?”

• Utilize_New.Notes 

4.3.6 Development Stage as “Licensed” and with Funding from NIH

When creating a Utilization Report with Development Stage as “Licensed” and the invention has a funding from NIH, 

there are additional FDA approved commercial product fields supported on top of the common fields. If the bulk file 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

17

content provided any data element fields not listed below, the values for the extra data elements will not be 

imported to the system. Refer to Table 4.3-1 for additional details for the data element fields. Specific examples for 

your reference can be found in section 5 of this document.

• Utilize_New.FiscalYear

• Utilize_New.LatestStageDev

• Utilize_New.ExclusiveLicensesOptions

• Utilize_New.ExclusiveLicenseeName

• Utilize_New.NonExclusiveLicensesOptions

• Utilize_New.NonExclusiveLicenseeName

• Utilize_New.SmallBusLicensesOptions

• Utilize_New.TotalIncome

• Utilize_New.IsUSManufacturingRequired1

o Value for “Other than U.S. Preference (35 U.S.C. 204), is the invention subject to any U.S. manufacturing 

requirements (e.g., U.S. Competitiveness provision, a U.S. Manufacturing DEC, etc.)?

• Utilize_New.IsUSManufacturingRequired2

o If Utilize_New.IsUSManufacturingRequired1 = ‘Y’, this data element value is for “In the designated 

reporting period, do all licenses include a requirement that any products embodying the subject 

invention or produced through the use of the subject invention will be manufactured substantially in the 

United States (including manufacturing requirements other than 35 U.S.C. 204)?”

o If Utilize_New.IsUSManufacturingRequired1 = ‘N’, this data element value is for “In the designated 

reporting period do all grants to any person having the exclusive right to use or sell the subject invention 

in the United States require that any products embodying the subject invention or produced through 

the use of the subject invention will be manufactured substantially in the United States as required by 

35 U.S.C. 204?”

• Utilize_New.Notes

• Utilize_New.CommercialName

• Utilize_New.FdaApprovalNumber

• Utilize_New.FdaApprovalType

• Utilize_New.GovtReviewStatus

• Utilize_New.PublicInd

4.3.7 Development Stage as “Licensed” and with Funding from DOE

When creating a Utilization Report with Development Stage as “Licensed” and the invention has a funding from 

DOE, there are additional DOE Supplemental question fields supported on top of the common fields. If the bulk file 

content provided any data element fields not listed below, the values for the extra data elements will not be 

imported to the system. Refer to Table 4.3-1 for additional details for the data element fields. Specific examples for 

your reference can be found in section 5 of this document.

• Utilize_New.FiscalYear

• Utilize_New.LatestStageDev

• Utilize_New.ExclusiveLicensesOptions

• Utilize_New.ExclusiveLicenseeName

• Utilize_New.NonExclusiveLicensesOptions
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

18

• Utilize_New.NonExclusiveLicenseeName

• Utilize_New.SmallBusLicensesOptions

• Utilize_New.TotalIncome

• Utilize_New.IsUSManufacturingRequired1

o Value for “Other than U.S. Preference (35 U.S.C. 204), is the invention subject to any U.S. manufacturing 

requirements (e.g., U.S. Competitiveness provision, a U.S. Manufacturing DEC, etc.)?

• Utilize_New.IsUSManufacturingRequired2

o If Utilize_New.IsUSManufacturingRequired1 = ‘Y’, this data element value is for “In the designated

reporting period, do all licenses include a requirement that any products embodying the subject 

invention or produced through the use of the subject invention will be manufactured substantially in the 

United States (including manufacturing requirements other than 35 U.S.C. 204)?”

o If Utilize_New.IsUSManufacturingRequired1 = ‘N’, this data element value is for “In the designated 

reporting period do all grants to any person having the exclusive right to use or sell the subject invention 

in the United States require that any products embodying the subject invention or produced through 

the use of the subject invention will be manufactured substantially in the United States as required by 

35 U.S.C. 204?”

• Utilize_New.Notes

• Utilize_New.NewUsJobs

• Utilize_New.NewUsCompanies

4.3.8 Development Stage as “Licensed” and with Funding from NIH and DOE

When creating a Utilization Report with Development Stage as “Licensed” and the invention has a funding from NIH 

and DOE, there are additional FDA approved commercial product fields and DOE Supplemental question fields 

supported on top of the common fields. If the bulk file content provided any data element fields not listed below, 

the values for the extra data elements will not be imported to the system. Refer to Table 4-3 for additional details 

for the data element fields. Specific examples for your reference can be found in section 5 of this document.

• Utilize_New.FiscalYear

• Utilize_New.LatestStageDev

• Utilize_New.ExclusiveLicensesOptions

• Utilize_New.ExclusiveLicenseeName

• Utilize_New.NonExclusiveLicensesOptions

• Utilize_New.NonExclusiveLicenseeName

• Utilize_New.SmallBusLicensesOptions

• Utilize_New.TotalIncome

• Utilize_New.IsUSManufacturingRequired1

o Value for “Other than U.S. Preference (35 U.S.C. 204), is the invention subject to any U.S. manufacturing 

requirements (e.g., U.S. Competitiveness provision, a U.S. Manufacturing DEC, etc.)?

• Utilize_New.IsUSManufacturingRequired2

o If Utilize_New.IsUSManufacturingRequired1 = ‘Y’, this data element value is for “In the designated 

reporting period, do all licenses include a requirement that any products embodying the subject 

invention or produced through the use of the subject invention will be manufactured substantially in the 

United States (including manufacturing requirements other than 35 U.S.C. 204)?”
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

19

o If Utilize_New.IsUSManufacturingRequired1 = ‘N’, this data element value is for “In the designated 

reporting period do all grants to any person having the exclusive right to use or sell the subject invention 

in the United States require that any products embodying the subject invention or produced through 

the use of the subject invention will be manufactured substantially in the United States as required by 

35 U.S.C. 204?”

• Utilize_New.Notes

• Utilize_New.CommercialName

• Utilize_New.FdaApprovalNumber

• Utilize_New.FdaApprovalType

• Utilize_New.GovtReviewStatus

• Utilize_New.PublicInd

• Utilize_New.NewUsJobs

• Utilize_New.NewUsCompanies

4.3.9 Development Stage as “Commercialized” 

When creating a Utilization Report with Development Stage as “Commercialized,” the data element fields are 

different depending on the funding agencies for the invention. If there is no funding from DOE or NIH, the DOE or 

NIH specific data elements are not needed. This section contains a list of data elements which can be use in this 

case. Refer to Table 4-3 for additional details for the data element fields. Specific examples for your reference can 

be found in section 5 of this document.

• Utilize_New.FiscalYear

• Utilize_New.LatestStageDev

• Utilize_New.ExclusiveLicensesOptions

• Utilize_New.ExclusiveLicenseeName

• Utilize_New.NonExclusiveLicensesOptions

• Utilize_New.NonExclusiveLicenseeName

• Utilize_New.SmallBusLicensesOptions

• Utilize_New.TotalIncome

• Utilize_New.IsUSManufacturingRequired1

o Value for “Other than U.S. Preference (35 U.S.C. 204), is the invention subject to any U.S. manufacturing 

requirements (e.g., U.S. Competitiveness provision, a U.S. Manufacturing DEC, etc.)?

• Utilize_New.IsUSManufacturingRequired2

o If Utilize_New.IsUSManufacturingRequired1 = ‘Y’, this data element value is for “In the designated 

reporting period, do all licenses include a requirement that any products embodying the subject 

invention or produced through the use of the subject invention will be manufactured substantially in the 

United States (including manufacturing requirements other than 35 U.S.C. 204)?”

o If Utilize_New.IsUSManufacturingRequired1 = ‘N’, this data element value is for “In the designated 

reporting period do all grants to any person having the exclusive right to use or sell the subject invention 

in the United States require that any products embodying the subject invention or produced through 

the use of the subject invention will be manufactured substantially in the United States as required by 

35 U.S.C. 204?”
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

20

• Utilize_New.IsUSManufacturingRequired3

o If Utilize_New.IsUSManufacturingRequired1 = ‘Y’, this data element value is for “In the designated 

reporting period, are all products embodying the subject invention or produced through the use of the 

subject invention manufactured substantially in the United States (including manufacturing 

requirements other than 35 U.S.C. 204)?”

o If Utilize_New.IsUSManufacturingRequired1 = ‘N’, this data element value is for “In the designated 

reporting period are all products embodying the subject invention or produced through the use of the 

subject invention manufactured substantially in the United States for all grants to any person having the 

exclusive right to use or sell the subject invention in the United States as required by 35 U.S.C. 204?”

• Utilize_New.FirstCommSaleYear

• Utilize_New.ProductName

• Utilize_New.LicenseeName

• Utilize_New.ManufacturerName

• Utilize_New.ManufacturerLocationCountry

• Utilize_New.ManufacturerLocationState

• Utilize_New.Notes 

4.3.10 Development Stage as “Commercialized” and Has Funding with NIH

When creating a Utilization with Development Stage as “Commercialized” and the invention has a funding from NIH, 

there are additional FDA-approved commercial product fields. This section contains a list of data elements which can 

be use in this case. Refer to Table 4.3-1 for additional details for the data element fields. Specific examples for your 

reference can be found in section 5 of this document.

• Utilize_New.FiscalYear

• Utilize_New.LatestStageDev

• Utilize_New.ExclusiveLicensesOptions

• Utilize_New.ExclusiveLicenseeName

• Utilize_New.NonExclusiveLicensesOptions

• Utilize_New.NonExclusiveLicenseeName

• Utilize_New.SmallBusLicensesOptions

• Utilize_New.TotalIncome

• Utilize_New.IsUSManufacturingRequired1

o Value for “Other than U.S. Preference (35 U.S.C. 204), is the invention subject to any U.S. manufacturing 

requirements (e.g., U.S. Competitiveness provision, a U.S. Manufacturing DEC, etc.)?

• Utilize_New.IsUSManufacturingRequired2

o If Utilize_New.IsUSManufacturingRequired1 = ‘Y’, this data element value is for “In the designated 

reporting period, do all licenses include a requirement that any products embodying the subject 

invention or produced through the use of the subject invention will be manufactured substantially in the 

United States (including manufacturing requirements other than 35 U.S.C. 204)?”

o If Utilize_New.IsUSManufacturingRequired1 = ‘N’, this data element value is for “In the designated 

reporting period do all grants to any person having the exclusive right to use or sell the subject invention 

in the United States require that any products embodying the subject invention or produced through 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

21

the use of the subject invention will be manufactured substantially in the United States as required by 

35 U.S.C. 204?”

• Utilize_New.IsUSManufacturingRequired3

o If Utilize_New.IsUSManufacturingRequired1 = ‘Y’, this data element value is for “In the designated 

reporting period, are all products embodying the subject invention or produced through the use of the 

subject invention manufactured substantially in the United States (including manufacturing 

requirements other than 35 U.S.C. 204)?”

o If Utilize_New.IsUSManufacturingRequired1 = ‘N’, this data element value is for “In the designated 

reporting period are all products embodying the subject invention or produced through the use of the 

subject invention manufactured substantially in the United States for all grants to any person having the 

exclusive right to use or sell the subject invention in the United States as required by 35 U.S.C. 204?”

• Utilize_New.FirstCommSaleYear

• Utilize_New.ProductName

• Utilize_New.LicenseeName

• Utilize_New.ManufacturerName

• Utilize_New.ManufacturerLocationCountry

• Utilize_New.ManufacturerLocationState

• Utilize_New.CommercialName

• Utilize_New.FdaApprovalNumber

• Utilize_New.FdaApprovalType

• Utilize_New.GovtReviewStatus

• Utilize_New.PublicInd

• Utilize_New.Notes

4.3.11 Development Stage as “Commercialized” and Has Funding with DOE

When creating a Utilization Report with Development Stage as “Commercialized” and the invention has a funding 

from DOE, there are additional DOE Supplemental question fields and DOE unique commercial product fields. This 

section contains a list of data elements which can be use in this case. Refer to Table 4.3-1 for additional details for 

the data element fields. Specific examples for your reference can be found in section 5 of this document.

• Utilize_New.FiscalYear

• Utilize_New.LatestStageDev

• Utilize_New.ExclusiveLicensesOptions

• Utilize_New.ExclusiveLicenseeName

• Utilize_New.NonExclusiveLicensesOptions

• Utilize_New.NonExclusiveLicenseeName

• Utilize_New.SmallBusLicensesOptions

• Utilize_New.TotalIncome

• Utilize_New.IsUSManufacturingRequired1

o Value for “Other than U.S. Preference (35 U.S.C. 204), is the invention subject to any U.S. manufacturing 

requirements (e.g., U.S. Competitiveness provision, a U.S. Manufacturing DEC, etc.)?

• Utilize_New.IsUSManufacturingRequired2

o If Utilize_New.IsUSManufacturingRequired1 = ‘Y’, this data element value is for “In the designated 

reporting period, do all licenses include a requirement that any products embodying the subject 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

22

invention or produced through the use of the subject invention will be manufactured substantially in the 

United States (including manufacturing requirements other than 35 U.S.C. 204)?”

o If Utilize_New.IsUSManufacturingRequired1 = ‘N’, this data element value is for “In the designated 

reporting period do all grants to any person having the exclusive right to use or sell the subject invention 

in the United States require that any products embodying the subject invention or produced through 

the use of the subject invention will be manufactured substantially in the United States as required by 

35 U.S.C. 204?”

• Utilize_New.IsUSManufacturingRequired3

o If Utilize_New.IsUSManufacturingRequired1 = ‘Y’, this data element value is for “In the designated 

reporting period, are all products embodying the subject invention or produced through the use of the 

subject invention manufactured substantially in the United States (including manufacturing 

requirements other than 35 U.S.C. 204)?”

o If Utilize_New.IsUSManufacturingRequired1 = ‘N’, this data element value is for “In the designated 

reporting period are all products embodying the subject invention or produced through the use of the 

subject invention manufactured substantially in the United States for all grants to any person having the 

exclusive right to use or sell the subject invention in the United States as required by 35 U.S.C. 204?”

• Utilize_New.FirstCommSaleYear

• Utilize_New.ProductName

• Utilize_New.LicenseeName

• Utilize_New.ManufacturerName

• Utilize_New.ManufacturerLocationCountry

• Utilize_New.ManufacturerLocationState

• Utilize_New.ProductQuantity

• Utilize_New.FirstDate

• Utilize_New.FirstDateType

• Utilize_New.Notes

• Utilize_New.NewUsJobs

• Utilize_New.NewUsCompanies

4.3.12 Development Stage as “Commercialized” and Has Funding with NIH and DOE

When creating a Utilization with Development Stage as “Commercialized” and the invention has a funding from NIH 

and DOE, there are additional FDA-approved commercial product fields for NIH, and additional DOE Supplemental 

question fields and DOE unique commercial product fields available. This section contains a list of data elements 

which can be use in this case. Refer to Table 4.3-1 for additional details for the data element fields. Specific 

examples for your reference can be found in section 5 of this document.

• Utilize_New.FiscalYear

• Utilize_New.LatestStageDev

• Utilize_New.ExclusiveLicensesOptions

• Utilize_New.ExclusiveLicenseeName

• Utilize_New.NonExclusiveLicensesOptions

• Utilize_New.NonExclusiveLicenseeName
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

23

• Utilize_New.SmallBusLicensesOptions

• Utilize_New.TotalIncome

• Utilize_New.IsUSManufacturingRequired1

o Value for “Other than U.S. Preference (35 U.S.C. 204), is the invention subject to any U.S. manufacturing 

requirements (e.g., U.S. Competitiveness provision, a U.S. Manufacturing DEC, etc.)?

• Utilize_New.IsUSManufacturingRequired2

o If Utilize_New.IsUSManufacturingRequired1 = ‘Y’, this data element value is for “In the designated 

reporting period, do all licenses include a requirement that any products embodying the subject 

invention or produced through the use of the subject invention will be manufactured substantially in the 

United States (including manufacturing requirements other than 35 U.S.C. 204)?”

o If Utilize_New.IsUSManufacturingRequired1 = ‘N’, this data element value is for “In the designated 

reporting period do all grants to any person having the exclusive right to use or sell the subject invention 

in the United States require that any products embodying the subject invention or produced through 

the use of the subject invention will be manufactured substantially in the United States as required by 

35 U.S.C. 204?”

• Utilize_New.IsUSManufacturingRequired3

o If Utilize_New.IsUSManufacturingRequired1 = ‘Y’, this data element value is for “In the designated 

reporting period, are all products embodying the subject invention or produced through the use of the 

subject invention manufactured substantially in the United States (including manufacturing 

requirements other than 35 U.S.C. 204)?”

o If Utilize_New.IsUSManufacturingRequired1 = ‘N’, this data element value is for “In the designated 

reporting period are all products embodying the subject invention or produced through the use of the 

subject invention manufactured substantially in the United States for all grants to any person having the 

exclusive right to use or sell the subject invention in the United States as required by 35 U.S.C. 204?”

• Utilize_New.FirstCommSaleYear

• Utilize_New.ProductName

• Utilize_New.LicenseeName

• Utilize_New.ManufacturerName

• Utilize_New.ManufacturerLocationCountry

• Utilize_New.ManufacturerLocationState

• Utilize_New.CommercialName

• Utilize_New.FdaApprovalNumber

• Utilize_New.FdaApprovalType

• Utilize_New.GovtReviewStatus

• Utilize_New.PublicInd

• Utilize_New.Notes

• Utilize_New.ProductQuantity

• Utilize_New.FirstDate

• Utilize_New.FirstDateType

• Utilize_New.NewUsJobs

• Utilize_New.NewUsCompanies
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

24

5 Examples 

This section contains examples of the bulk upload file content with the data element name and value pairs.

5.1 Create Invention Example

This is an example of creating an Invention Report. The system will check if the EIR.DocketNum value already 

exists in the system. If the value is not in iEdison, the system will create a new Invention Report.

PRODUCTION

EIR.DocketNum =^^GMU.07.005^^ 

EIR.PrimaryAgency =^^NIST^^ 

EIR.Title =^^Self-Cleansing Instrusion Tolerance with Short Exposure Times^^ 

EIR_Grants.Agency=^^NIST^^ 

EIR_Grants.GrantNum=^^60NANB2D0108^^ 

EIR_Inventor.LastName=^^Huang^^ 

EIR_Inventor.FirstName=^^Yih^^ 

EIR_Inventor.LastName=^^ Arsenault ^^ 

EIR_Inventor.FirstName=^^David^^ 

EIR_Inventor.LastName=^^Sood^^ 

EIR_Inventor.FirstName=^^Arun^^ 

5.2 Create Invention, Patent, and Utilization Example

This is an example of creating an Invention, Patent, and Utilization Report in a single bulk upload file. The system 

will first perform a check to see if the EIR.DocketNum value already exists in the system. If it does, the system will 

not create any new records. If the value does not exist in the system, the system will then perform a validation 

check on the other required fields. If the validation check passes, the system will create a new Invention Report, 

Patent Report, and Utilization Report. As shown in the example, the patent and utilization data elements must be 

after the invention data elements.

PRODUCTION

EIR.DocketNum =^^GMU.07.005^^ 

EIR.PrimaryAgency =^^NIST^^ 

EIR.Title =^^Self-Cleansing Instrusion Tolerance with Short Exposure Times^^ 

EIR_Grants.Agency=^^NIST^^ 

EIR_Grants.GrantNum=^^60NANB2D0108^^ 

EIR_Inventor.LastName=^^Huang^^ 

EIR_Inventor.FirstName=^^Yih^^ 

EIR_Inventor.LastName=^^ Arsenault ^^ 

EIR_Inventor.FirstName=^^David^^ 

EIR_Inventor.LastName=^^Sood^^ 

EIR_Inventor.FirstName=^^Arun^^ 

Patent.PatDocketNum=^^GMU-07-005U^^ 

Patent.NonProvAppNum=^^11/857,055^^ 

Patent.NonProvAppDate=^^09/18/2007^^ 

Patent.TypeOfApplic=^^ORD^^ 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

25

Patent.PatentTitle=^^Self-Cleansing Instrusion Tolerance with Short Exposure Times ^^ 

Pat_Inventor.LastName=^^Huang ^^ 

Pat_Inventor.FirstName=^^Yin^^ 

Pat_Inventor.LastName=^^Arsenault^^ 

Pat_Inventor.FirstName=^^David^^ 

Pat_Inventor.LastName=^^Sood^^ 

Pat_Inventor.FirstName=^^Arun^^ 

Utilize_New.FiscalYear=^^2023^^ 

Utilize_New.LatestStageDev=^^ Not Licensed or Commercialized ^^ 

Utilize_New. CommercializationPlanId=^^6^^ 

Utilize_New.NewUsJobs=^^1090^^

Utilize_New.NewUsCompanies=^^125^^

Utilize_New. Notes=^^This is description for utilization version 2^^ 

5.3 Create Invention and Multiple Patent Reports Example

This is an example of creating an Invention, Patent, and Utilization Report in a single bulk upload file. The system 

will check if the EIR.DocketNum value already exists in the system and other validations for required fields. If the 

value is not in iEdison and passes validation checks, the system will create an invention Report and Patent

Reports. As shown in the example, the patent data elements must be after the invention data elements.

PRODUCTION

EIR.DocketNum =^^GMU.07.005^^ 

EIR.PrimaryAgency =^^NIST^^ 

EIR.Title =^^Self-Cleansing Instrusion Tolerance with Short Exposure Times^^ 

EIR_Grants.Agency =^^NIST^^ 

EIR_Grants.GrantNum =^^60NANB2D0108^^ 

EIR_Inventor.LastName =^^Huang^^ 

EIR_Inventor.FirstName =^^Yih^^ 

EIR_Inventor.LastName =^^ Arsenault ^^ 

EIR_Inventor.FirstName =^^David^^ 

EIR_Inventor.LastName =^^Sood^^ 

EIR_Inventor.FirstName =^^Arun^^ 

Patent.PatDocketNum =^^GMU-07-005U^^ 

Patent.NonProvAppNum =^^11/857,055^^ 

Patent.NonProvAppDate =^^09/18/2007^^ 

Patent.TypeOfApplication=^^ORD^^ 

Patent.PatentTitle=^^Self-Cleansing Instrusion Tolerance with Short Exposure Times ^^ 

Patent.Inventor.LastName=^^Huang ^^ 

Patent.Inventor.FirstName=^^Yin^^ 

Patent.Inventor.LastName=^^Arsenault^^ 

Patent.Inventor.FirstName=^^David^^ 

Patent.Inventor.LastName=^^Sood^^ 

Patent.Inventor.FirstName=^^Arun^^ 

Patent.DocketNumber=^^GMU-07-005P2^^ 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

26

Patent.ProvApplicationNumber=^^60/826,107^^ 

Patent.ProvApplicationDate=^^09/19/2006^^ 

Patent.TypeOfApplic =^^PROV^^ 

Patent.PatentTitle =^^Single Use Server System^^ 

Pat_Inventor.LastName =^^Huang ^^ 

Pat_Inventor.FirstName =^^Yin^^ 

Pat_Inventor.LastName =^^Arsenault^^ 

Pat_Inventor.FirstName =^^David^^ 

Pat_Inventor.LastName =^^Sood^^ 

Pat_Inventor.FirstName =^^Arun^^ 

5.4 Create Invention and Utilization Reports Example

This is an example of creating an Invention, Patent, and Utilization Report in a single bulk upload file. The system 

will check if the EIR.DocketNum value already exists in the system and other validations for required fields. If the 

value is not in iEdison and passes validation checks, the system will create a new Invention Report and 

PatentReports. As shown in the example, the utilization data elements must be after the invention data elements.

PRODUCTION

Invention.DocketNumber=^^GMU.07.005^^ 

EIR.PrimaryAgency =^^NIST^^ 

EIR.Title =^^Self-Cleansing Instrusion Tolerance with Short Exposure Times^^ 

EIR_Grants.Agency =^^NIST^^ 

EIR_Grants.GrantNum =^^60NANB2D0108^^ 

EIR_Inventor.LastName =^^Huang^^ 

EIR_Inventor.FirstName =^^Yih^^ 

EIR_Inventor.LastName =^^ Arsenault ^^ 

EIR_Inventor.FirstName =^^David^^ 

EIR_Inventor.LastName =^^Sood^^ 

EIR_Inventor.FirstName =^^Arun^^ 

Utilize_New.FiscalYear =^^2023^^

Utilize_New. LatestStageDev =^^Licensed^^ 

Utilize_New. ExclusiveLicensesOptions =^^2^^ 

Utilize_New.ExclusiveLicenseeName=^^License Name 1^^

Utilize_New.ExclusiveLicenseeName=^^License Name 2^^

Utilize_New.NonExclusiveLicensesOptions=^^3^^

Utilize_New.NonExclusiveLicenseeName=^^Non License name 1^^

Utilize_New.NonExclusiveLicenseeName=^^Non license name 2^^

Utilize_New.NonExclusiveLicenseeName=^^Non License name 3^^

Utilize_New. SmallBusLicensesOptions =^^5^^ 

Utilize_New.IsUSManufacturingRequired1=^^Y^^ 

Utilize_New.IsUSManufacturingRequired2=^^N^^ 

Utilize_New.IsUSManufacturingRequired3=^^Y^^ 

Utilize_New.NewUsJobs=^^1090^^

Utilize_New.NewUsCompanies=^^125^^
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

27

Utilize_New.Notes=^^Another note for utilization 2^^ 

5.5 Create a Utilization Report with Development Stage (Not Licensed or Commercialized) with NIH Funding 

Example

This section contains an example of creating a Utilization with Development Stage as “Not Licensed or 

Commercialized” and with NIH funding to an existing Invention Report. The invention data field only has 

EIR.DocketNum because it is the unique invention identifier within an organization. There are additional data 

element fields to collect the FDA-approved commercial products utilizing this invention that have first reached the 

market during the designated reporting period.

PRODUCTION

EIR.DocketNum=^^23-0072^^

Utilize_New.FiscalYear=^^2023^^

Utilize_New.LatestStageDev=^^Not Licensed or Commercialized^^

Utilize_New.CommercializationPlanId=^^6^^

Utilize_New.CommercialName =^^NIH Product 1^^

Utilize_New.FdaApprovalNumber=^^NIHAPPROVALONE^^

Utilize_New.PublicInd=^^Yes^^

Utilize_New.GovtReviewStatus=^^Approved^^

Utilize_New.FdaApprovalType=^^Medical Device^^

Utilize_New.CommercialName =^^NIH Product 2^^

Utilize_New.FdaApprovalNumber=^^NIHAPPROVALTWO^^

Utilize_New.PublicInd=^^Yes^^

Utilize_New.GovtReviewStatus=^^Rejected^^

Utilize_New.FdaApprovalType=^^Drug^^

Utilize_New.CommercialName =^^NIH Product 3^^

Utilize_New.FdaApprovalNumber=^^NIHAPPROVALTHREE^^

Utilize_New.PublicInd=^^No^^

Utilize_New.FdaApprovalType=^^Biologic^^

Utilize_New.Notes=^^This is the first test for utilization version 2^^

5.6 Create a Utilization Version 2 with Development Stage as “Licensed” Example

This section contains an example of creating a Utilization Report with Development Stage as “Licensed” and with 

NIH funding to an existing Invention Report. The invention data field only has EIR.DocketNum because it is the 

unique invention identifier within an organization.

PRODUCTION

EIR.DocketNum=^^23-0073^^

Utilize_New.FiscalYear=^^2023^^

Utilize_New.LatestStageDev=^^Licensed^^

Utilize_New.ExclusiveLicensesOptions=^^3^^

Utilize_New.ExclusiveLicenseeName=^^Name Option 1^^

Utilize_New.ExclusiveLicenseeName=^^Name Option 2^^
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

28

Utilize_New.ExclusiveLicenseeName=^^Name Option 3^^

Utilize_New.NonExclusiveLicensesOptions=^^4^^

Utilize_New.NonExclusiveLicenseeName=^^Non Name option 1^^

Utilize_New.NonExclusiveLicenseeName=^^Non Name option 2^^

Utilize_New.NonExclusiveLicenseeName=^^Non Name option 3^^

Utilize_New.NonExclusiveLicenseeName=^^Non Name option 4^^

Utilize_New.TotalIncome=^^156.69^^

Utilize_New.IsUSManufacturingRequired1=^^Y^^

Utilize_New.IsUSManufacturingRequired2=^^N^^

Utilize_New.IsUSManufacturingRequired3=^^Y^^

Utilize_New.SmallBusLicensesOptions=^^10^^

Utilize_New.NewUsJobs=^^1090^^

Utilize_New.NewUsCompanies=^^125^^

Utilize_New.CommercialName =^^NIH Product 1 Licensed^^

Utilize_New.FdaApprovalNumber=^^NIHAPPROVALONE^^

Utilize_New.PublicInd=^^Yes^^

Utilize_New.GovtReviewStatus=^^Approved^^

Utilize_New.FdaApprovalType=^^Medical Device^^

Utilize_New.Notes=^^This is the test utilization version 2 category licensed for the notes^^

5.7 Create a Utilization Report with Development Stage (Commercialized) with NIH Funding Example

This section contains an example of creating a Utilization Report with Development Stage as “Commercialized” 

and with NIH funding to an existing Invention Report. The invention data field only has EIR.DocketNum because 

it is the unique invention identifier within an organization. 

PRODUCTION

EIR.DocketNum=^^23-0074^^

Utilize_New.FiscalYear=^^2023^^

Utilize_New.LatestStageDev=^^Commercialized^^

Utilize_New.ExclusiveLicensesOptions=^^3^^

Utilize_New.ExclusiveLicenseeName=^^Commercialized Name Option 1^^

Utilize_New.ExclusiveLicenseeName=^^Commercialized Name Option 2^^

Utilize_New.ExclusiveLicenseeName=^^Commercialized Name Option 3^^

Utilize_New.NonExclusiveLicensesOptions=^^4^^

Utilize_New.NonExclusiveLicenseeName=^^Commercialized Non Name option 1^^

Utilize_New.NonExclusiveLicenseeName=^^Commercialized Non Name option 2^^

Utilize_New.NonExclusiveLicenseeName=^^Commercialized Non Name option 3^^

Utilize_New.NonExclusiveLicenseeName=^^Commercialized Non Name option 4^^

Utilize_New.TotalIncome=^^1560.69^^

Utilize_New.IsUSManufacturingRequired1=^^Y^^

Utilize_New.IsUSManufacturingRequired2=^^N^^

Utilize_New.IsUSManufacturingRequired3=^^Y^^

Utilize_New.SmallBusLicensesOptions=^^991^^

Utilize_New.FirstCommSaleYear=^^2023^^
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

29

Utilize_New.ProductName=^^Commercial Product 1^^

Utilize_New.LicenseeName=^^Commercialized Name Option 1^^

Utilize_New.ManufacturerName=^^ABC 1 1^^

Utilize_New.ManufacturerLocationCountry=^^KENYA^^

Utilize_New.ManufacturerLocationCountry=^^UGANDA^^

Utilize_New.ManufacturerLocationCountry=^^UNITED STATES^^

Utilize_New.ManufacturerLocationState=^^MARYLAND^^

Utilize_New.ManufacturerName=^^ABC 1 1 A^^

Utilize_New.ManufacturerLocationCountry=^^CANADA^^

Utilize_New.ManufacturerLocationCountry=^^GERMANY^^

Utilize_New.ManufacturerName=^^ABC 1 1 B^^

Utilize_New.ManufacturerLocationCountry=^^CHINA^^

Utilize_New.ManufacturerLocationCountry=^^TAIWAN^^

Utilize_New.CommercialName=^^NIH Product 1 Licensed^^

Utilize_New.FdaApprovalNumber=^^NIHAPPROVALONE^^

Utilize_New.PublicInd=^^Yes^^

Utilize_New.GovtReviewStatus=^^Approved^^

Utilize_New.FdaApprovalType=^^Medical Device^^

Utilize_New.CommercialName=^^NIH Product 2 Licensed^^

Utilize_New.FdaApprovalNumber=^^NIHAPPROVALTWO^^

Utilize_New.PublicInd=^^Yes^^

Utilize_New.GovtReviewStatus=^^Rejected^^

Utilize_New.FdaApprovalType=^^Drug^^

Utilize_New.Notes=^^This is the test utilization version 2 category Commercialized for the notes^^

5.8 Create a Utilization Report for 2023 and after (Commercialized with DOE and NIH Questions)

This section contains an example of creating a Utilization Report with Development Stage as “Commercialized” 

and with DOE funding and NIH funding to an existing Invention Report. The invention data field only has

EIR.DocketNum because it is the unique invention identifier within an organization. This example includes the 

DOE and NIH special data elements and how they are grouped.

PRODUCTION

EIR.DocketNum=^^23-0076^^

Utilize_New.FiscalYear=^^2023^^

Utilize_New.LatestStageDev=^^Commercialized^^

Utilize_New.ExclusiveLicensesOptions=^^2^^

Utilize_New.ExclusiveLicenseeName=^^Commercialized Name Option 1^^

Utilize_New.ExclusiveLicenseeName=^^Commercialized Name Option 2^^

Utilize_New.NonExclusiveLicensesOptions=^^2^^

Utilize_New.NonExclusiveLicenseeName=^^Commercialized Non Name option 1^^

Utilize_New.NonExclusiveLicenseeName=^^Commercialized Non Name option 2^^

Utilize_New.TotalIncome=^^660.69^^

Utilize_New.IsUSManufacturingRequired1=^^Y^^

Utilize_New.IsUSManufacturingRequired2=^^N^^
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

30

Utilize_New.IsUSManufacturingRequired3=^^Y^^

Utilize_New.SmallBusLicensesOptions=^^968^^

Utilize_New.FirstCommSaleYear=^^2023^^

Utilize_New.NewUsJobs=^^20^^

Utilize_New.NewUsCompanies=^^5^^

Utilize_New.ProductName=^^Commercial Product 1^^

Utilize_New.NaicsCode=^^XYZ^^

Utilize_New.LicenseeName=^^Commercialized Name Option 1^^

Utilize_New.ManufacturerName=^^ABC 1 1^^

Utilize_New.ManufacturerLocationCountry=^^KENYA^^

Utilize_New.ProductQuantity=^^178^^

Utilize_New.FirstDate=^^11/26/2023^^

Utilize_New.FirstDateType=^^Actual^^

Utilize_New.ManufacturerLocationCountry=^^UGANDA^^

Utilize_New.ManufacturerLocationCountry=^^UNITED STATES^^

Utilize_New.ManufacturerLocationState=^^MARYLAND^^

Utilize_New.ManufacturerName=^^ABC 1 1 A^^

Utilize_New.ManufacturerLocationCountry=^^CANADA^^

Utilize_New.ManufacturerLocationCountry=^^GERMANY^^

Utilize_New.ManufacturerName=^^ABC 1 1 B^^

Utilize_New.ManufacturerLocationCountry=^^CHINA^^

Utilize_New.ManufacturerLocationCountry=^^TAIWAN^^

Utilize_New.ProductName=^^NIH Product 1 Licensed^^

Utilize_New.FdaApprovalNumber=^^NIHAPPROVALONE^^

Utilize_New.PublicInd=^^Yes^^

Utilize_New.GovtReviewStatus=^^Approved^^

Utilize_New.FdaApprovalType=^^Medical Device^^

Utilize_New.Notes=^^This is the test utilization version 2 category Commercialized for the notes^^

5.9 Create a Utilization Report for 2023 and after (Commercialized and has both NIH and DOE funding)

This is section contains an example of creating a Utilization with Development Stage as “Commercialized” and the 

invention has a funding from NIH and DOE. There are additional FDA-approved commercial product fields for NIH, 

and additional DOE Supplemental question fields and DOE unique commercial product fields available. This 

example contains a list of data elements which can be use in this case. 

PRODUCTION

Invention.DocketNumber=^^23-0132^^

Utilize_New.FiscalYear=^^2023^^

Utilize_New.LatestStageDev=^^Commercialized^^

Utilize_New.ExclusiveLicensesOptions=^^3^^

Utilize_New.ExclusiveLicenseeName=^^Commercialized Name Option 1^^

Utilize_New.ExclusiveLicenseeName=^^Commercialized Name Option 2^^

Utilize_New.ExclusiveLicenseeName=^^Commercialized Name Option 3^^

Utilize_New.NonExclusiveLicensesOptions=^^4^^
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

31

Utilize_New.NonExclusiveLicenseeName=^^Commercialized Non Name option 1^^

Utilize_New.NonExclusiveLicenseeName=^^Commercialized Non Name option 2^^

Utilize_New.NonExclusiveLicenseeName=^^Commercialized Non Name option 3^^

Utilize_New.NonExclusiveLicenseeName=^^Commercialized Non Name option 4^^

Utilize_New.SmallBusLicensesOptions=^^991^^

Utilize_New.TotalIncome=^^100560.69^^

Utilize_New.IsUSManufacturingRequired1=^^Y^^

Utilize_New.IsUSManufacturingRequired2=^^N^^

Utilize_New.IsUSManufacturingRequired3=^^Y^^

Utilize_New.FirstCommSaleYear=^^2023^^

Utilize_New.NewUsJobs=^^20^^

Utilize_New.NewUsCompanies=^^5^^

Utilize_New.Notes=^^This is the test note for the Commercialized new utilization via Bulk upload!^^

Utilize_New.ProductName=^^DOE Commercial Product 1^^

Utilize_New.NaicsCode=^^XYZ^^

Utilize_New.LicenseeName=^^Commercialized Name Option 1^^

Utilize_New.ManufacturerName=^^Intel^^

Utilize_New.ManufacturerLocationCountry=^^FRANCE^^

Utilize_New.ProductQuantity=^^100^^

Utilize_New.FirstDate=^^12/01/2023^^

Utilize_New.FirstDateType=^^Actual^^

Utilize_New.ManufacturerLocationCountry=^^UNITED STATES^^

Utilize_New.ManufacturerLocationState=^^ARIZONA^^

Utilize_New.ProductQuantity=^^10000^^

Utilize_New.FirstDate=^^01/01/2024^^

Utilize_New.FirstDateType=^^Actual^^

Utilize_New.CommercialName=^^NIH Product 1 Commercialized^^

Utilize_New.PublicInd=^^Yes^^

Utilize_New.FdaApprovalType=^^Medical Device^^

Utilize_New.FdaApprovalNumber=^^NIHAP12345^^

Utilize_New.GovtReviewStatus=^^Approved^^

Utilize_New.CommercialName=^^NIH Product 2 Commercialized^^

Utilize_New.PublicInd=^^Yes^^

Utilize_New.FdaApprovalType=^^Drug^^

Utilize_New.FdaApprovalNumber=^^NIHAP6789^^

Utilize_New.GovtReviewStatus=^^Rejected^^

5.10 Update Invention Report Examples

This is section contains an example of how to update the invention disclosure date and add two new inventors to 

the invention.

PRODUCTION

EIR.DocketNum=^^TEST.NEWINVXX^^

EIR_Inventor.LastName=^^Lee^^
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

32

EIR_Inventor.FirstName=^^Michael^^

EIR_Inventor.LastName=^^Doe^^

EIR_Inventor.FirstName=^^Jane^^

EIR.DisclosurDate=^^9/03/2023^^

5.11 Update Patent Report Examples

This is section contains an example of how to update the Patent Report with Non-Provisional Application Date, 

Issued Patent Number, Issued Patent Date, and Expiration Date.

PRODUCTION

EIR.DocketNum=^^TEST.NEWINVXX^^

Patent.PatDocketNum=^^TEST.NEWPAT^^

Patent.NonProvAppNum=^^90/991,171^^

Patent.NonProvAppDate=^^09/04/2023^^

Patent.PatentNum=^^PP1,234^^

Patent.PatentDate=^^09/01/2023^^

Patent.ExpireDate=^^01/01/2027^^

5.12 Update Utilization Examples

The EIR.DocketNum and Utilize_New.FiscalYear data element fields uniquely identify which Utilization Report the 

bulk upload is updating. The system will check if there is an existing Invention Report with the given docket 

number value from EIR.DocketNum data element and check if there is an existing Utilization Report with report 

year value of the Utilize_New.FiscalYear data element. If the Invention is found with the given EIR.DocketNum 

value and a Utilization Report is found with the given Utilize_New.FiscalYear in the invention, the system will then 

look for other data element fields starts with Utilize_New to update. However, there is a limitation on the 

utilization update feature currently. There are limited data elements supported with utilizations and they are:

• Utilize_New.CommercializationPlanId

• Utilize_New.SmallBusLicensesOptions

• Utilize_New.TotalIncome

• Utilize_New.IsUSManufacturingRequired1

• Utilize_New.IsUSManufacturingRequired2

• Utilize_New.IsUSManufacturingRequired3

• Utilize_New.FirstCommSaleYear

• Utilize_New.Notes

• Utilize_New.NewUsJobs

• Utilize_New.NewUsCompanies

The rest of the data elements are not currently supported. They will be supported in a future release. Below is an 

example of updating the TotalIncome, SmallBusLicensesOptions, and Notes.

PRODUCTION

EIR.DocketNum=^^TEST.NEWINVXX^^

Utilize_New.FiscalYear=^^2023^^
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

33

Utilize_New.TotalIncome=^^1900.99^^

Utilize_New.SmallBusLicensesOptions=^^10^^

Utilize_New.Notes=^^This is the test utilization version 2 category licensed for the notes. Updated text in the 

notes^^

6 Lookups 

The tables below contain lookup values used for the Bulk Upload tool 

6.1 Agency List and Abbreviation 

This section contains a list of the Abbreviations and Agency Names. The Abbreviation value is used in the bulk 

upload file content Primary Agency and Funding Agency.

Abbreviation Agency Name

AHRQ Agency for Healthcare Research and Quality

ARMY/ARL Army Research Laboratory

ARMY/ARO Army Research Laboratory - Army Research Office

ARMY/MRDC Medical Research and Development Command

ARMY/SMDC U.S. Army Space & Missile Defense Command

CDC Centers for Disease Control and Prevention

DHS/ST Department of Homeland Security, Science and Technology

DOC/EDA Economic Development Administration

DOD/DARPA Defense Advanced Research Projects Agency

DOD/DMEA Defense Microelectronics Activity

DOD/DTRA Defense Threat Reduction Agency

DOE U.S. Department of Energy

DOT U.S. Department of Transportation

FAA Federal Aviation Administration

FBI Federal Bureau of Investigation

FDA Food and Drug Administration

NIDILRR National Institute on Disability, Independent Living and Rehabilitation Research

NIH National Institutes of Health

NIST National Institute of Standards and Technology

NOAA National Oceanic and Atmospheric Administration

NRC U.S. Nuclear Regulatory Commission

NRL Naval Research Laboratory

NSF National Science Foundation

OTHER Other Agency

USAID U.S. Agency for International Development

USDA/ARS Agricultural Research Service

USDA/NIFA National Institute of Food and Agriculture

USGS U.S. Geological Survey
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

34

6.2 Award Type 

This section contains a list of valid values for the funding agreement Award Type.

Value 

Prime Award 

Sub-Award 

6.3 Agreement Type

This section contains a list of valid values for the funding agreement Agreement Type.

Value 

ACT = DoE Specific 

Cooperative Agreement 

Contract 

Grant 

Other Transaction 

6.4 Title Election Status 

This section contains a list of valid values to use in the bulk upload for the invention’s title election status.

Value 

Under Evaluation 

Elect to Retain Title 

Does Not Retain Title 

Designated as Unpatented Biological Material 

or Research Tool 

Government Takes Title (Award Terms)
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

35

6.5 State List 

This section contains a list of all valid United States state and territory names.

Value 

ALABAMA 

ALASKA 

ARIZONA 

ARKANSAS 

CALIFORNIA 

COLORADO 

CONNECTICUT 

DELAWARE 

DIST OF COL 

FLORIDA 

GEORGIA 

HAWAII 

IDAHO 

ILLINOIS 

INDIANA 

IOWA 

KANSAS 

KENTUCKY 

LOUISIANA 

MAINE 

MARYLAND 

MASSACHUSETTS 

MICHIGAN 

MINNESOTA 

MISSISSIPPI 

MISSOURI 

MONTANA 

NEBRASKA 

NEVADA 

NEW HAMPSHIRE 

NEW JERSEY 

NEW MEXICO 

NEW YORK 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

36

NORTH CAROLINA 

NORTH DAKOTA 

OHIO 

OKLAHOMA 

OREGON 

PENNSYLVANIA 

RHODE ISLAND 

SOUTH CAROLINA 

SOUTH DAKOTA 

TENNESSEE 

TEXAS 

UTAH 

VERMONT 

VIRGINIA 

WASHINGTON 

WEST VIRGINIA 

WISCONSIN 

WYOMING 

AMERICAN SAMOA 

FED MICRONESIA 

GUAM 

MARSHALL IS 

NORTHN MARIANA 

PALAU 

PUERTO RICO 

US MINOR OUTLY 

VIRGIN ISLANDS 

ALBERTA 

BR. COLUMBIA 

MANITOBA 

NEW BRUNSWICK 

NW TERRITORIES 

NOVA SCOTIA 

ONTARIO 

PR. EDWARD ISL 

QUEBEC 

SASKATCHEWAN 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

37

YUKON 

QUEBEC 

AP0/FP0 S AMER 

AP0/FP0 EUROPE 

AP0/FP0 OT PAC 

NAVASSA ISLAND 

BAKER ISLAND 

HOWARD ISLAND 

JOHNSTON ATOLL 

KINGMAN REEF 

PALMYRA ATOLL 

MIDWAY ISLANDS 

TRUST TER PACF 

WAKE ISLAND 

NEWFOUNDLAND 

6.6 Country List 

This section contains a list of valid country name to use in the bulk upload file content.

Value 

AFGHANISTAN 

ALBANIA 

ALGERIA 

ANDORRA 

ANGOLA 

ANGUILLA 

ANTIGUA/BARBUD 

ARMENIA 

ARGENTINA 

ARUBA 

AUSTRALIA 

AUSTRIA 

AZERBAIJAN 

BAHAMAS 

BAHRAIN 

BANGLADESH 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

38

BARBADOS 

BELARUS

BELGIUM 

BELIZE 

BENIN 

BERMUDA 

BHUTAN 

BOLIVIA 

BOSNIA/HERZEG 

BOTSWANA 

BRAZIL 

BRITISH VI ISS 

BRUNEI 

BULGARIA 

BURKINA

BURUNDI 

CABO VERDE

CAMBODIA 

CAMEROON 

CANADA 

CAYMAN ISLANDS 

CENTRAL AFR R 

CHAD 

CHILE 

CHINA 

COLOMBIA 

COMOROS 

CONGO 

CONGO DEM REP

COSTA RICA 

COTE D'IVOIRE

CROATIA 

CUBA 

CYPRUS 

CZECH REPUBLIC 

DENMARK 

DJIBOUTI

DOMINICA 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

39

DOMINICAN REP 

ECUADOR 

EGYPT 

EL SALVADOR 

EQUATOR GUINEA 

ERITREA

ESTONIA

ESWATINI

ETHIOPIA

FALKLAND ISS 

FIJI 

FINLAND 

FRANCE 

FRENCH POLYNES 

GABON

GAMBIA

GAZA STRIP

GEORGIA

GERMANY 

GHANA 

GIBRALTAR 

GREECE 

GREENLAND 

GRENADA 

GUATEMALA 

GUERNSEY 

GUINEA 

GUINEA-BISSAU 

GUYANA 

HAITI 

HONDURAS 

HONG KONG 

HUNGARY 

ICELAND 

INDIA 

INDONESIA 

IRAN 

IRAQ 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

40

IRELAND 

ISRAEL 

ITALY 

JAMAICA

JAPAN

JERSEY

JORDAN

KAZAKHSTAN

KENYA

KIRIBATI

KOREA PEO REP

KOREA REP OF

KOSOVO

KUWAIT

KYRGYZSTAN

LAOS

LATVIA

LEBANON

LESOTHO

LIBERIA

LIBYA

LIECHTENSTEIN

LITHUANIA

LUXEMBOURG

MACAU

MADAGASCAR

MALAWI

MALAYSIA

MALDIVES

MALI

MALTA

MAURITANIA

MAURITIUS

MEXICO

MOLDOVA

MONACO
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

41

MONGOLIA

MONTENEGRO

MONTSERRAT

MOROCCO

MOZAMBIQUE

MYANMAR

NAMIBIA

NAURU

NEPAL

NETHERLANDS

NEW ZEALAND

NICARAGUA

NIGER

NIGERIA

NORTH MACEDONIA

NORWAY

OMAN

PAKISTAN

PANAMA

PAPUA N GUINEA

PARAGUAY

PERU

PHILIPPINES

POLAND

PORTUGAL

QATAR

ROMANIA

RUSSIA

RWANDA

SAMOA

SAN MARINO

SAO TOME/PRINC

SAUDI ARABIA

SENEGAL

SERBIA

SEYCHELLES
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

42

SIERRA LEONE

SINGAPORE

SLOVAKIA

SLOVENIA

SOLOMON ISS

SOMALIA

SOUTH AFRICA

SOUTH SUDAN

SPAIN

SRI LANKA

ST HELENA

ST KITTS/NEVIS

ST LUCIA

ST VINCENT/GRN

SUDAN

SURINAME

SWEDEN

SWITZERLAND

SYRIA

TAIWAN

TAJIKISTAN

TANZANIA U REP

THAILAND

TIMOR-LESTE

TOGO

TONGA

TRINIDAD/TOBA

TUNISIA

TURKEY

TURKMENISTAN

TURKS/CAICOS I

TUVALU

UGANDA

UKRAINE

UNITED ARAB EM

UNITED KINGDOM
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

43

UNITED STATES

URUGUAY

UZBEKISTAN

VANUATU

VENEZUELA

VIETNAM

WEST BANK

YEMEN

YUGOSLAVIA

ZAMBIA

ZIMBABWE

6.7 Patent Status 

Value 

INSTITUTION RETAINS RIGHTS 

6.8 Patent Type 

Value 

CIP (Continuation-In-Part) 

CON (Continuation) 

DIV (Divisional) 

ORD/UTIL 

PROV (Provisional) 

PVP (Plant Variety Protection) 

PCT (Patent Cooperation Treaty Application)

6.9 Foreign Filing Status 

Value 

ABANDONED 

ACTIVE 

6.10 Reporting Year 

Value 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

44

2023 ( Version 2)

2024

2025

2026

2027

2028 

2029

2030

2031

2032

2033

2034

6.11 Latest Development Stage 

Value 

Not Licensed or Commercialized

Licensed 

Commercialized

6.12 First Commercial Sale

Value 

2022 

2021 

2020 

2019 

2018 

2017 

2016 

2015 

2014 

2013 

2012 

2011 
Invention, Patent, and Utilization Version 2

Bulk Upload Specifications, Report Year 2023 and Later

 

45

Drug

6.13 Type of date of manufacturer

Value

Actual

Expected

6.14 Government review status

Value

Approved

Rejected

Pending

6.15 FDA Approval Type

Value

Biologic

Medical Device

Drug

6.16 Commercialization Plans

Use the digit value in the “Value” column in the Bulk Upload data element

Value Description

1 Seeking additional funding to further develop this invention

2 Marketing and/or furthering development of this invention to attract commercial 

partners

3 Developing and/or using this invention for internal purposes only

4 Developing and/or preparing this invention with intent to commercialize ourselves

5 Making available for distribution and/or licensing for research purposes only

6 No current commercialization plan